share_log

Bernstein Adjusts Price Target on Regeneron Pharmaceuticals to $1,110 From $1,135

Bernstein Adjusts Price Target on Regeneron Pharmaceuticals to $1,110 From $1,135

柏瑞资本将再生元制药公司的目标股价从1,135美元调整为1,110美元。
MT Newswires ·  2024/11/01 21:02  · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发